Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retention in endoplasmic reticulum sorting receptor 1 (RER1) is a multi-pass transmembrane sorting receptor primarily localized at the cis-Golgi and intermediate compartment. Its main function is to retrieve escaped endoplasmic reticulum (ER) membrane proteins and unassembled subunits of oligomeric complexes from the cis-Golgi back to the ER, preserving compartmentalization and ensuring proper complex assembly[3][5]. It recognizes specific motifs in the transmembrane domains of substrate proteins, thereby contributing to ER quality control[3][1][4]. RER1 is conserved from yeast (Rer1p) to mammals, and is implicated in neurological processes by influencing γ-secretase assembly and amyloid-β production, linking it to neurodegenerative disease pathways[3]. At present, there are no approved drugs targeting RER1, and it is not categorized as a therapeutic target in clinical practice[3][5].
Not applicable (no known drugs directly target RER1)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retention in endoplasmic reticulum sorting receptor 1 (RER1).